Infant Bacterial Therapeutics AB (9IB.F) Q4 2025 Earnings

Nov 13Confirmed
Q4 2025
-0.07
0.27
0.6
0.93

Details

Expected EPS
N/A
Actual EPS
-0.0682975575
Surprise EPS
N/A
Surprise Percent
N/A

Description

⁨Infant Bacterial Therapeutics AB⁩ (⁦9IB.F⁩) has reported earnings of ⁦-0.0682975575⁩ per share for ⁦Q4 2025⁩.

0 Comments

Share your thoughts